HomeVSTM • NASDAQ
Verastem Inc
$11.80
Mar 28, 5:01:11 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$11.82
Day range
$11.68 - $12.10
Year range
$4.20 - $15.19
Market cap
298.49M USD
Avg Volume
169.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
Operating expense
31.14M84.85%
Net income
-27.37M-62.83%
Net profit margin
Earnings per share
-1.10-14.58%
EBITDA
-31.13M-85.13%
Effective tax rate
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
137.13M56.02%
Total assets
149.72M57.51%
Total liabilities
71.18M49.36%
Total equity
78.53M
Shares outstanding
25.30M
Price to book
5.21
Return on assets
-47.78%
Return on capital
-56.02%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-27.37M-62.83%
Cash from operations
-29.68M-78.63%
Cash from investing
12.44M-4.52%
Cash from financing
-446.00K
Net change in cash
-17.69M-392.65%
Free cash flow
-14.45M-42.39%
About
Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Employees
73
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu